Evaluation of symptom severity, tolerability, and physical function in the I-SPY2 trial.
Year: 2023
Type: conference-abstract
Source: JCO Oncology Practice
Authors: Amrita B Basu, Saumya Umashankar, Mina Musthafa, Tamia Jones, Kaylee Blevins, Thelma Brown, Diane Heditsian, Beverly Parker, Susie Brain, Carol Simmons, Tina J. Hieken, Kathryn Jean Ruddy, Candace Bavette Mainor, Sarah Emily Amend Tevis, Anne Hudson Blaes, Hope S. Rugo, Imogene Dunn, Michelle E. Melisko, Laura Esserman, Dawn L. Hershman
Institutions: University of California, San Francisco, University of Alabama, Living Beyond Breast Cancer, Mayo Clinic, MedStar Georgetown University Hospital, Georgetown Lombardi Comprehensive Cancer Center, Masonic Cancer Center, UCSF Helen Diller Family Comprehensive Cancer Center, Quantum Leap Healthcare Collaborative, Columbia University
Language: English
Topic: Cancer survivorship and care
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4387962158